S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NYSE:ABEV

Ambev (ABEV) Competitors

$2.98
0.00 (0.00%)
(As of 06/7/2023 ET)
Compare
Today's Range
$2.96
$3.03
50-Day Range
$2.77
$2.99
52-Week Range
$2.40
$3.24
Volume
13.91 million shs
Average Volume
21.04 million shs
Market Capitalization
$47.01 billion
P/E Ratio
16.58
Dividend Yield
4.02%
Price Target
$3.74

ABEV vs. KDP, STZ, BF.B, DEO, KMB, KHC, KVUE, GIS, CTVA, and ADM

Should you be buying Ambev stock or one of its competitors? The main competitors of Ambev include Keurig Dr Pepper (KDP), Constellation Brands (STZ), Brown-Forman (BF.B), Diageo (DEO), Kimberly-Clark (KMB), Kraft Heinz (KHC), Kenvue (KVUE), General Mills (GIS), Corteva (CTVA), and Archer-Daniels-Midland (ADM). These companies are all part of the "consumer staples" sector.

Ambev vs.

Ambev (NYSE:ABEV) and Keurig Dr Pepper (NASDAQ:KDP) are both large-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

8.8% of Ambev shares are owned by institutional investors. Comparatively, 52.3% of Keurig Dr Pepper shares are owned by institutional investors. 0.8% of Keurig Dr Pepper shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Ambev and Ambev both had 5 articles in the media. Ambev's average media sentiment score of 1.33 beat Keurig Dr Pepper's score of 0.83 indicating that Ambev is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ambev
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Keurig Dr Pepper
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ambev received 352 more outperform votes than Keurig Dr Pepper when rated by MarketBeat users. Likewise, 60.60% of users gave Ambev an outperform vote while only 26.19% of users gave Keurig Dr Pepper an outperform vote.

CompanyUnderperformOutperform
AmbevOutperform Votes
363
60.60%
Underperform Votes
236
39.40%
Keurig Dr PepperOutperform Votes
11
26.19%
Underperform Votes
31
73.81%

Ambev has a net margin of 18.00% compared to Keurig Dr Pepper's net margin of 9.20%. Ambev's return on equity of 17.44% beat Keurig Dr Pepper's return on equity.

Company Net Margins Return on Equity Return on Assets
Ambev 18.00% 17.44% 11.02%
Keurig Dr Pepper 9.20% 9.52% 4.64%

Ambev has higher revenue and earnings than Keurig Dr Pepper. Ambev is trading at a lower price-to-earnings ratio than Keurig Dr Pepper, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ambev$15.44 billion3.05$2.80 billion$0.1816.58
Keurig Dr Pepper$14.06 billion3.13$1.44 billion$0.9333.67

Ambev has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500. Comparatively, Keurig Dr Pepper has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.

Ambev pays an annual dividend of $0.12 per share and has a dividend yield of 4.0%. Keurig Dr Pepper pays an annual dividend of $0.80 per share and has a dividend yield of 2.6%. Ambev pays out 66.7% of its earnings in the form of a dividend. Keurig Dr Pepper pays out 86.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ambev is clearly the better dividend stock, given its higher yield and lower payout ratio.

Ambev currently has a consensus target price of $3.74, indicating a potential upside of 25.29%. Keurig Dr Pepper has a consensus target price of $37.56, indicating a potential upside of 19.95%. Given Ambev's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ambev is more favorable than Keurig Dr Pepper.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ambev
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Keurig Dr Pepper
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Ambev beats Keurig Dr Pepper on 13 of the 19 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABEV vs. The Competition

MetricAmbevBeverages IndustryStaples SectorNYSE Exchange
Market Cap$47.01B$49.42B$15.22B$14.92B
Dividend Yield4.26%2.19%2.98%3.99%
P/E Ratio16.5812.1814.8819.37
Price / Sales3.0578.264.509.33
Price / Cash11.0920.3320.0423.61
Price / Book2.935.136.017.36
Net Income$2.80B$1.73B$680.75M$901.01M
7 Day Performance6.42%-0.15%3.52%6.14%
1 Month Performance3.29%-2.16%1.74%4.27%
1 Year Performance6.99%-12.26%-8.42%-7.00%

Ambev Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KDP
Keurig Dr Pepper
2.1327 of 5 stars
$31.00
-1.3%
$37.56
+21.1%
-15.3%$43.52B$14.06B33.3328,000
STZ
Constellation Brands
2.193 of 5 stars
$237.06
+1.8%
$252.58
+6.5%
-1.4%$43.44B$10.18B-464.8110,700Analyst Report
BF.B
Brown-Forman
1.6067 of 5 stars
$61.53
-0.1%
$68.33
+11.1%
-5.6%$29.49B$3.93B40.755,200Earnings Report
News Coverage
DEO
Diageo
1.4519 of 5 stars
$170.02
-2.3%
N/A-9.4%$95.88B$19.43B0.0028,137Analyst Report
KMB
Kimberly-Clark
2.3944 of 5 stars
$133.55
-2.0%
$134.45
+0.7%
+2.8%$45.06B$20.18B22.8744,000
KHC
Kraft Heinz
2.4175 of 5 stars
$37.85
-1.3%
$43.79
+15.7%
+3.0%$46.45B$26.49B19.3137,000Analyst Upgrade
KVUE
Kenvue
1.7754 of 5 stars
$25.73
-2.2%
N/AN/A$48.60BN/A0.0022,200
GIS
General Mills
2.1187 of 5 stars
$83.27
-1.1%
$84.76
+1.8%
+21.8%$48.91B$18.99B17.9832,500Gap Down
CTVA
Corteva
2.2789 of 5 stars
$54.97
-0.4%
$72.75
+32.3%
-6.6%$39.08B$17.46B33.9321,000
ADM
Archer-Daniels-Midland
2.673 of 5 stars
$71.46
-1.7%
$100.78
+41.0%
-18.1%$38.92B$101.85B8.9742,001

Related Companies and Tools

This page (NYSE:ABEV) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -